Chapter/Section Purchase

1 Multi-ingredient Codeine Market Overview
1.1 Product Overview and Scope of Multi-ingredient Codeine
1.2 Multi-ingredient Codeine Segment by Type
1.2.1 Global Multi-ingredient Codeine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 15mg
1.2.3 30mg
1.2.4 60mg
1.3 Multi-ingredient Codeine Segment by Application
1.3.1 Global Multi-ingredient Codeine Sales Comparison by Application: (2022-2028)
1.3.2 Narcotic Analgesic
1.3.3 Antitussive
1.3.4 Others
1.4 Global Multi-ingredient Codeine Market Size Estimates and Forecasts
1.4.1 Global Multi-ingredient Codeine Revenue 2017-2028
1.4.2 Global Multi-ingredient Codeine Sales 2017-2028
1.4.3 Multi-ingredient Codeine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Multi-ingredient Codeine Market Competition by Manufacturers
2.1 Global Multi-ingredient Codeine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Multi-ingredient Codeine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Multi-ingredient Codeine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Multi-ingredient Codeine Manufacturing Sites, Area Served, Product Type
2.5 Multi-ingredient Codeine Market Competitive Situation and Trends
2.5.1 Multi-ingredient Codeine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Multi-ingredient Codeine Players Market Share by Revenue
2.5.3 Global Multi-ingredient Codeine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Multi-ingredient Codeine Retrospective Market Scenario by Region
3.1 Global Multi-ingredient Codeine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Multi-ingredient Codeine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Multi-ingredient Codeine Market Facts & Figures by Country
3.3.1 North America Multi-ingredient Codeine Sales by Country
3.3.2 North America Multi-ingredient Codeine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Multi-ingredient Codeine Market Facts & Figures by Country
3.4.1 Europe Multi-ingredient Codeine Sales by Country
3.4.2 Europe Multi-ingredient Codeine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Multi-ingredient Codeine Market Facts & Figures by Region
3.5.1 Asia Pacific Multi-ingredient Codeine Sales by Region
3.5.2 Asia Pacific Multi-ingredient Codeine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Multi-ingredient Codeine Market Facts & Figures by Country
3.6.1 Latin America Multi-ingredient Codeine Sales by Country
3.6.2 Latin America Multi-ingredient Codeine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Multi-ingredient Codeine Market Facts & Figures by Country
3.7.1 Middle East and Africa Multi-ingredient Codeine Sales by Country
3.7.2 Middle East and Africa Multi-ingredient Codeine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Multi-ingredient Codeine Historic Market Analysis by Type
4.1 Global Multi-ingredient Codeine Sales Market Share by Type (2017-2022)
4.2 Global Multi-ingredient Codeine Revenue Market Share by Type (2017-2022)
4.3 Global Multi-ingredient Codeine Price by Type (2017-2022)
5 Global Multi-ingredient Codeine Historic Market Analysis by Application
5.1 Global Multi-ingredient Codeine Sales Market Share by Application (2017-2022)
5.2 Global Multi-ingredient Codeine Revenue Market Share by Application (2017-2022)
5.3 Global Multi-ingredient Codeine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Taiji
6.1.1 Taiji Corporation Information
6.1.2 Taiji Description and Business Overview
6.1.3 Taiji Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Taiji Multi-ingredient Codeine Product Portfolio
6.1.5 Taiji Recent Developments/Updates
6.2 Mallinckrodt
6.2.1 Mallinckrodt Corporation Information
6.2.2 Mallinckrodt Description and Business Overview
6.2.3 Mallinckrodt Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Mallinckrodt Multi-ingredient Codeine Product Portfolio
6.2.5 Mallinckrodt Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 TEVA Multi-ingredient Codeine Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson Multi-ingredient Codeine Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Medreich
6.5.1 Medreich Corporation Information
6.5.2 Medreich Description and Business Overview
6.5.3 Medreich Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Medreich Multi-ingredient Codeine Product Portfolio
6.5.5 Medreich Recent Developments/Updates
6.6 Sanofi Aventis
6.6.1 Sanofi Aventis Corporation Information
6.6.2 Sanofi Aventis Description and Business Overview
6.6.3 Sanofi Aventis Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Sanofi Aventis Multi-ingredient Codeine Product Portfolio
6.6.5 Sanofi Aventis Recent Developments/Updates
6.7 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Cipla Multi-ingredient Codeine Product Portfolio
6.7.5 Cipla Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Corporation Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hikma Multi-ingredient Codeine Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Pharmaceutical Associates
6.9.1 Pharmaceutical Associates Corporation Information
6.9.2 Pharmaceutical Associates Description and Business Overview
6.9.3 Pharmaceutical Associates Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Pharmaceutical Associates Multi-ingredient Codeine Product Portfolio
6.9.5 Pharmaceutical Associates Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Novartis Multi-ingredient Codeine Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Multi-ingredient Codeine Description and Business Overview
6.11.3 Apotex Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Apotex Multi-ingredient Codeine Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Mylan
6.12.1 Mylan Corporation Information
6.12.2 Mylan Multi-ingredient Codeine Description and Business Overview
6.12.3 Mylan Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Mylan Multi-ingredient Codeine Product Portfolio
6.12.5 Mylan Recent Developments/Updates
6.13 Aristo Pharma GmbH
6.13.1 Aristo Pharma GmbH Corporation Information
6.13.2 Aristo Pharma GmbH Multi-ingredient Codeine Description and Business Overview
6.13.3 Aristo Pharma GmbH Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Aristo Pharma GmbH Multi-ingredient Codeine Product Portfolio
6.13.5 Aristo Pharma GmbH Recent Developments/Updates
6.14 Lannett Company
6.14.1 Lannett Company Corporation Information
6.14.2 Lannett Company Multi-ingredient Codeine Description and Business Overview
6.14.3 Lannett Company Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Lannett Company Multi-ingredient Codeine Product Portfolio
6.14.5 Lannett Company Recent Developments/Updates
6.15 Laboratoire Riva
6.15.1 Laboratoire Riva Corporation Information
6.15.2 Laboratoire Riva Multi-ingredient Codeine Description and Business Overview
6.15.3 Laboratoire Riva Multi-ingredient Codeine Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Laboratoire Riva Multi-ingredient Codeine Product Portfolio
6.15.5 Laboratoire Riva Recent Developments/Updates
7 Multi-ingredient Codeine Manufacturing Cost Analysis
7.1 Multi-ingredient Codeine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Multi-ingredient Codeine
7.4 Multi-ingredient Codeine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Multi-ingredient Codeine Distributors List
8.3 Multi-ingredient Codeine Customers
9 Multi-ingredient Codeine Market Dynamics
9.1 Multi-ingredient Codeine Industry Trends
9.2 Multi-ingredient Codeine Market Drivers
9.3 Multi-ingredient Codeine Market Challenges
9.4 Multi-ingredient Codeine Market Restraints
10 Global Market Forecast
10.1 Multi-ingredient Codeine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Multi-ingredient Codeine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Multi-ingredient Codeine by Type (2023-2028)
10.2 Multi-ingredient Codeine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Multi-ingredient Codeine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Multi-ingredient Codeine by Application (2023-2028)
10.3 Multi-ingredient Codeine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Multi-ingredient Codeine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Multi-ingredient Codeine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer